Skip to main content
Glama

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed1 schema field changed
    • changedInput schema / properties / value / description
      Previous value: -"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed (\"NEW YORK ST DORM AUTH\"), never the question's full noun phrase (\"NEW YORK ST DORM AUTH revenue bonds\"): the FIGI lookup matches instrument names, so trailing security-class words match nothing."
  2. Changed3 schema fields changed
    • changedInput schema / properties / type / description
      Previous value: -"Entity type. v1 supports \"company\"."New value: +"Entity type: \"company\" or \"drug\"."
    • changedInput schema / properties / type / enum
      Previous value: -[
      -  "company"
      -]New value: +[
      +  "company",
      +  "drug"
      +]
    • changedInput schema / properties / value / description
      Previous value: -"Ticker, CIK, or company name (e.g., \"AAPL\", \"0000320193\", \"Apple\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."
  3. Added

TDQS

A4.6/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

The description discloses rich behavioral details beyond the annotations: it cascades through multiple lookup endpoints, degrades gracefully when GLEIF or OpenFIGI is unavailable, returns figi_candidates when a name is ambiguous, and explicitly lists unresolved identifiers rather than omitting them. It also explains that identifiers are labelled with their source. This far exceeds what readOnlyHint and idempotentHint already convey, with no contradiction.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness5/5

Is the description appropriately sized, front-loaded, and free of redundancy?

Although the description is long, it is densely packed with useful information and front-loaded with the most important directive: 'Use FIRST whenever you have a name but need an ID.' Every sentence adds either a behavioral nuance, a supported-type detail, or a parameter edge case, so the length is justified rather than padded.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

With no output schema, the description carries the burden of explaining return values, and it does so: it lists the exact identifiers returned per type (CIK, ticker, company_name, LEI plus ownership, FIGI, RxCUI, ingredient, brand), mentions source labelling, and explains the unresolved case. An agent has enough context to call the tool and interpret its response correctly.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, so the baseline is 3, but the description adds substantial meaning beyond the schema. It tells the agent exactly how to format the `value` parameter, including the crucial warning to pass only the entity name and not the full noun phrase, with a concrete example ('NEW YORK ST DORM AUTH' vs 'NEW YORK ST DORM AUTH revenue bonds'). This is genuinely actionable parameter guidance.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose4/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states a specific action—resolving a user-spoken name to canonical/official identifiers—and enumerates the exact resources and identifiers involved (CIK, ticker, LEI, FIGI, RxCUI). It is not simply restating the title, and the examples make the purpose unambiguous. However, it does not explicitly contrast itself with sibling tools like entity_profile or compare_entities, so it falls short of a perfect 5.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

It gives an explicit directive: 'Use FIRST whenever you have a name but need an ID.' It also explains when the tool will return candidates instead of asserting a single answer, and it clarifies that non-equity instruments without tickers still resolve here. It does not explicitly name alternative tools or say when not to use this tool, so it is slightly shy of full usage-guideline coverage.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.6/5.0
Disambiguation1/5

Multiple tools have nearly identical purposes: ask_pipeworx and ask_pipeworx_beta are explicitly described as identical, and ask_pipeworx_grounded differs only in grounding. generate_users and generate_by_gender overlap, as do ai_visibility_check/scan_competitor_ai_presence and the several polymarket_* tools that all target edge detection and arbitrage. An agent would struggle to select the correct tool.

Naming Consistency2/5

All names use snake_case, but the pattern is inconsistent: some start with verbs (generate_users, resolve_entity, validate_claim), some are nouns (entity_profile, deep_research, recent_changes), and some are compound noun phrases (ai_visibility_check, pipeworx_feedback, polymarket_arbitrage). There is no predictable verb_noun structure across the set.

Tool Count2/5

33 tools is well above the 'too many' threshold, and the set includes many meta-tools, memory helpers, and niche prediction-market tools. While the broad domain might justify some diversity, the count feels bloated and dilutes the server's focus, especially given the server name suggests only random user generation.

Completeness4/5

For the apparent core domain (data lookups, research, prediction market analysis, subscriptions), the tool surface is quite comprehensive: it covers direct queries, grounded answers, deep research, entity profiles, comparisons, claim verification, discovery, trends, memory, and subscription management. Minor gaps exist (e.g., no direct CRUD for user-generated profiles beyond creation), but overall the feature set feels well covered.